Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$11.05 - $16.62 $14,155 - $21,290
-1,281 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$11.69 - $14.54 $14,974 - $18,625
1,281 New
1,281 $16,000
Q4 2019

Feb 13, 2020

SELL
$6.71 - $9.55 $4,978 - $7,086
-742 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$6.0 - $9.6 $4,452 - $7,123
742 New
742 $7,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $24.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.